WEBJAX® Mice Strain BALB/cJ. Stock Number 000651. 160 female and 160 male mice were obtained at weaning (birthdate +/- 3 days) from two barrier levels (standard and maximum) from both Bar Harbor and Sacramento facilities, and weighed weekly until the oldest age held in inventory.
WEBGrowth data to be used as guideline only. Data can be subject to differences in maintenance of mice. Growth chart includes mean + 2 SD's representative of population distribution.
WEBPhysiological Data Summary – BALB/cByJ (001026) Revised: December 13, 2007. Complete data with range and standard deviations available from the Mouse Phenome Database (MPD, www.jax.org/phenome) Parameter. Units. Females. Males. Hematology.
WEBOverview. Nomenclature: BALB/cAnNTac. A general purpose inbred strain for many different research disciplines. Often used for the production of monoclonal antibodies using hybridomas of BALB/c spleen cell origin. It exhibits good breeding performance and long reproductive life span.
WEBJun 11, 2024 · Growth and Survival Curves of BALB/c-Il10KO Mice. Disease Incidence and Disease Activity Index (DAI) The disease incidence in BALB/c-Il10 KO mice was quantitatively analyzed based on the Disease Activity Index (DAI) and Crohn's Disease Activity Index (CDAI).
WEBBALB/cOlaHsd-Foxn1nu Production Facility 308020-room 5, Gannat - FR (2020) Maintained on Teklad Global Rodent Diet 2919S (19% Protein) Cage floor space (MB1): 960 cm2 Age (weeks) Growth data to be used as guideline only. Data can be subject to differences in maintenance of mice.
WEBGrowth data to be used as guideline only. Data can be subject to differences in maintenance of mice. Growth chart includes mean + 2 SD's representative of population distribution.
WEBThis subline is the most widely-used for the production of monoclonal antibodies by hybridoma technique. Males are non-aggressive and easy to handle. Origin. The Laboratory Animal Center (Lac) received the BALB/c Bom inbred model from …
WEBGrowth curves for immunocompetent BALB/c mice for tumors grown after the (A) first inoculation and (B) rechallenge inoculation, which occurred 18 days after treatment of the first tumor.